Syra Health Corp. (SYRA)
OTCMKTS · Delayed Price · Currency is USD
0.8000
0.00 (0.00%)
At close: Aug 28, 2026
Syra Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8.09 | 7.23 | 7.98 | 5.52 | 5.62 | 1.41 | |
Revenue Growth | 0.32% | -9.47% | 44.73% | -1.83% | 298.43% | - |
Cost of Revenue | 4.91 | 4.74 | 6.33 | 4.1 | 4.59 | 0.98 |
Gross Profit | 3.18 | 2.49 | 1.65 | 1.41 | 1.03 | 0.43 |
Selling, General & Admin | 3.04 | 3.3 | 4.77 | 4.01 | 3.11 | 0.43 |
Research & Development | 0.06 | 0.07 | 0.59 | 0.24 | - | - |
Operating Expenses | 3.11 | 3.39 | 5.42 | 4.3 | 3.12 | 0.43 |
Operating Income | 0.07 | -0.9 | -3.76 | -2.89 | -2.09 | -0 |
Interest Expense | -0.01 | -0.01 | -0.02 | -0.05 | -0.03 | - |
Interest & Investment Income | 0.07 | 0.02 | 0.02 | 0 | 0 | - |
Pretax Income | 0.13 | -0.9 | -3.76 | -2.94 | -2.12 | -0 |
Net Income | 0.13 | -0.9 | -3.76 | -2.94 | -2.12 | -0 |
Net Income to Common | 0.13 | -0.9 | -3.76 | -2.94 | -2.12 | -0 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 12 | 12 | 8 | 14 | 12 | 14 |
Shares Outstanding (Diluted) | 12 | 12 | 8 | 14 | 12 | 14 |
Shares Change | 22.44% | 56.95% | -45.76% | 16.97% | -13.44% | - |
EPS (Basic) | 0.01 | -0.08 | -0.50 | -0.21 | -0.18 | -0.00 |
EPS (Diluted) | 0.01 | -0.08 | -0.50 | -0.21 | -0.18 | -0.00 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 0.11 | -0.45 | -2.94 | -2.77 | -2.37 | -0.09 |
Free Cash Flow Per Share | 0.01 | -0.04 | -0.39 | -0.20 | -0.20 | -0.01 |
Gross Margin | 39.35% | 34.43% | 20.71% | 25.60% | 18.35% | 30.52% |
Operating Margin | 0.92% | -12.52% | -47.17% | -52.36% | -37.20% | -0.23% |
Profit Margin | 1.62% | -12.40% | -47.10% | -53.28% | -37.70% | -0.23% |
Free Cash Flow Margin | 1.35% | -6.20% | -36.87% | -50.30% | -42.10% | -6.70% |
EBITDA | 0.09 | -0.88 | -3.7 | -2.84 | -2.07 | -0 |
EBITDA Margin | 1.09% | -12.18% | -46.38% | -51.47% | -36.93% | -0.22% |
D&A For EBITDA | 0.01 | 0.02 | 0.06 | 0.05 | 0.01 | 0 |
EBIT | 0.07 | -0.9 | -3.76 | -2.89 | -2.09 | -0 |
EBIT Margin | 0.92% | -12.52% | -47.17% | -52.36% | -37.20% | -0.23% |
Revenue as Reported | - | - | - | - | - | 1.41 |